Loading...

Zoetis Inc.

0M3Q.LLSE
Healthcare
Medical - Pharmaceuticals
£164.76
£-2.99(-1.78%)

Zoetis Inc. 0M3Q.L Peers

See (0M3Q.L) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
0M3Q.L£164.76-1.78%73.4B37.80£4.36+1.14%
0R0H.L£406.26-2.11%153.4B21.17£19.19+0.50%
0QZU.L£457.48-0.31%117.5B48.28£9.48N/A
0R2M.L£526.06+1.00%55.8B7.48£70.31+0.33%
0HD2.L£306.29+2.70%39.9B-40.89-£7.49N/A
0RD1.L£603.79-1.30%36.9B-475.43-£1.27N/A
0HAV.L£118.01-1.21%33.5B28.47£4.15+0.82%
0JDM.L£158.43-0.63%27.4B28.61£5.54N/A
0K10.L£1,171.16-1.99%24.3B34.40£34.05N/A
0REZ.L£195.80+0.67%24B33.37£5.87+0.38%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

0M3Q.L vs 0R0H.L Comparison

0M3Q.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0M3Q.L stands at 73.4B. In comparison, 0R0H.L has a market cap of 153.4B. Regarding current trading prices, 0M3Q.L is priced at £164.76, while 0R0H.L trades at £406.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0M3Q.L currently has a P/E ratio of 37.80, whereas 0R0H.L's P/E ratio is 21.17. In terms of profitability, 0M3Q.L's ROE is +0.51%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0M3Q.L is less volatile compared to 0R0H.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3Q.L.

Stock Price Comparison

Loading...

Frequently Asked Questions